Bacitracin, Neomycin, Polymyxin B

12 adverse event reports submitted to the FDA

Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.

Total Reports

Deaths Reported

2500.0%

Death Rate

Active Ingredients

Bacitracin, Neomycin, Polymyxin B

Administration Routes

OphthalmicTopicalUnknownAuricular (Otic)Oral

Species Affected

Dog 8

Cat 4

Most Affected Breeds

Domestic (unspecified) 2

Domestic Shorthair 2

Schnauzer (unspecified) 1

Maltese 1

Retriever - Flat-coated 1

Poodle - Toy 1

Shih Tzu 1

Retriever - Labrador 1

Retriever - Golden 1

Unknown 1

Most Reported Reactions

Diarrhoea 3

Vomiting 2

Deafness 2

Death by euthanasia 2

Tachypnoea 2

Hypotension 2

Lethargy (see also Central nervous system depression in 'Neurological') 2

Polypnoea 1

Anaphylaxis 1

Tachycardia 1

Weakness 1

Pleural effusion 1

Outcome Breakdown

Died

2 (25.0%)

Recovered/Normal

2 (25.0%)

Ongoing

2 (25.0%)

Outcome Unknown

1 (12.5%)

Euthanized

1 (12.5%)

Source: FDA Center for Veterinary Medicine — Adverse Event Reports. Data reflects voluntary submissions and may not represent actual incidence rates.